KRX •
Healthcare •
Biotechnology •
Quote as of 06/19/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization1,780,333 mln
Float22.61 mln
Relative Strength
41
/ 100
Slightly lagging
Debt / Equity
0.01
Debt-free
ROE
3.44
Very low
DPS
0.00
Business Description
Aimed Bio Inc. is a South Korean biotech company founded in 2018 that focuses on treating serious brain conditions such as brain cancer and degenerative neurological disorders. The company combines several research approaches to develop new treatments, including methods to deliver drugs across the blood-brain barrier and tools to better understand how the brain's immune system responds to disease. Patient-derived laboratory models are also central to their work, helping the team test and refine potential therapies in ways that closely reflect real patient biology.
